The Role of Extracorporeal Ventricular Assist Device is Changing in the Era of Implantable Ventricular Assist Device

研究成果: ジャーナルへの寄稿記事

抄録

In the era of implantable ventricular assist device (VAD), the role of extracorporeal VAD is changing. The extracorporeal VAD was ever the mainstream of treatment for severe heart failure. Now, it is mainly applied to patients with severe cardiogenic shock. Recently the centrifugal pump available for cardiopulmonary bypass system has been often used as the extracorporeal VAD because of its simplicity of management. Although the implantable VAD plays the pivotal role for bridge to transplantation since its clinical introduction in 2011, the extracorporeal VAD still has the important role for end-stage heart failure and cardiogenic shock. We have experienced 47 cases of the extracorporeal VAD until now. Here, based on our experience, we describe the "past and present" role of the extracorporeal VAD and mention the future aspect of the extracorporeal VAD.

元の言語英語
ページ(範囲)513-518
ページ数6
ジャーナルKyobu geka. The Japanese journal of thoracic surgery
71
発行部数7
出版物ステータス出版済み - 7 1 2018

Fingerprint

Heart-Assist Devices
Cardiogenic Shock
Heart Failure
Cardiopulmonary Bypass
Transplantation

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

@article{194a58f9c29441389e2ab247c6ad6a8b,
title = "The Role of Extracorporeal Ventricular Assist Device is Changing in the Era of Implantable Ventricular Assist Device",
abstract = "In the era of implantable ventricular assist device (VAD), the role of extracorporeal VAD is changing. The extracorporeal VAD was ever the mainstream of treatment for severe heart failure. Now, it is mainly applied to patients with severe cardiogenic shock. Recently the centrifugal pump available for cardiopulmonary bypass system has been often used as the extracorporeal VAD because of its simplicity of management. Although the implantable VAD plays the pivotal role for bridge to transplantation since its clinical introduction in 2011, the extracorporeal VAD still has the important role for end-stage heart failure and cardiogenic shock. We have experienced 47 cases of the extracorporeal VAD until now. Here, based on our experience, we describe the {"}past and present{"} role of the extracorporeal VAD and mention the future aspect of the extracorporeal VAD.",
author = "Tomoki Ushijima and Akira Shiose",
year = "2018",
month = "7",
day = "1",
language = "English",
volume = "71",
pages = "513--518",
journal = "Japanese Journal of Thoracic Surgery",
issn = "0021-5252",
publisher = "Nankodo Co., Ltd.",
number = "7",

}

TY - JOUR

T1 - The Role of Extracorporeal Ventricular Assist Device is Changing in the Era of Implantable Ventricular Assist Device

AU - Ushijima, Tomoki

AU - Shiose, Akira

PY - 2018/7/1

Y1 - 2018/7/1

N2 - In the era of implantable ventricular assist device (VAD), the role of extracorporeal VAD is changing. The extracorporeal VAD was ever the mainstream of treatment for severe heart failure. Now, it is mainly applied to patients with severe cardiogenic shock. Recently the centrifugal pump available for cardiopulmonary bypass system has been often used as the extracorporeal VAD because of its simplicity of management. Although the implantable VAD plays the pivotal role for bridge to transplantation since its clinical introduction in 2011, the extracorporeal VAD still has the important role for end-stage heart failure and cardiogenic shock. We have experienced 47 cases of the extracorporeal VAD until now. Here, based on our experience, we describe the "past and present" role of the extracorporeal VAD and mention the future aspect of the extracorporeal VAD.

AB - In the era of implantable ventricular assist device (VAD), the role of extracorporeal VAD is changing. The extracorporeal VAD was ever the mainstream of treatment for severe heart failure. Now, it is mainly applied to patients with severe cardiogenic shock. Recently the centrifugal pump available for cardiopulmonary bypass system has been often used as the extracorporeal VAD because of its simplicity of management. Although the implantable VAD plays the pivotal role for bridge to transplantation since its clinical introduction in 2011, the extracorporeal VAD still has the important role for end-stage heart failure and cardiogenic shock. We have experienced 47 cases of the extracorporeal VAD until now. Here, based on our experience, we describe the "past and present" role of the extracorporeal VAD and mention the future aspect of the extracorporeal VAD.

UR - http://www.scopus.com/inward/record.url?scp=85063712536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063712536&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 513

EP - 518

JO - Japanese Journal of Thoracic Surgery

JF - Japanese Journal of Thoracic Surgery

SN - 0021-5252

IS - 7

ER -